Globus Medical (GMED)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	1,020,302	873,161	813,563	793,599	759,118	743,436	725,952	717,944	718,879	703,240	691,074	602,183	571,579	561,900	553,727	605,997	605,393	592,470	573,029	558,227
Revenue (ttm)	US$ in thousands	1,568,476	1,226,440	1,096,949	1,068,982	1,022,843	998,366	973,939	961,307	958,102	941,526	927,903	825,809	789,042	767,264	747,381	792,998	785,368	769,639	742,660	721,505
Gross profit margin		65.05%	71.19%	74.17%	74.24%	74.22%	74.47%	74.54%	74.68%	75.03%	74.69%	74.48%	72.92%	72.44%	73.23%	74.09%	76.42%	77.08%	76.98%	77.16%	77.37%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $1,020,302K ÷ $1,568,476K
= 65.05%

Globus Medical Inc's gross profit margin has shown a varying trend over the past eight quarters. The margin decreased from 74.68% in Q1 2022 to 65.05% in Q4 2023, indicating a decline in profitability in the most recent quarter. However, it is worth noting that the gross profit margin was relatively stable at around 74-75% for the majority of the periods analyzed.

The fluctuations in the gross profit margin may be attributable to changes in the cost of goods sold, pricing strategies, or product mix. It is essential for the company to closely monitor and manage its cost structure to ensure sustainable profitability levels.

Additionally, further analysis of the factors impacting gross profit margin, such as operational efficiency, pricing dynamics, and cost management, would provide a more comprehensive understanding of Globus Medical Inc's financial performance.